| If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| | | ![]() TUNA Effective In Treating BPH For At Least One Year FREMONT, CA -- March 19, 1998 – A study published in this month’s issue of the journal Urology shows that VidaMed’s TUNA(R) Procedure (transurethral needle ablation) provides sustained and lasting improvement in the key measures used to determine prostate function at 12 months. The study, conducted at several major university medical centres around the country, included 130 patients who had been treated with the TUNA procedure. All patients who participated in this study were treated with local anesthesia augmented by oral and/or parenteral sedation and no patients (93 patients followed) required retreatment at one year. "It would appear that the TUNA system will find its place in the urologists' armamentarium for the treatment of symptomatic benign prostatic hyperplasia (BPH) in those patients not willing to undergo TURP because of fear of the surgery itself, its complication, and/or the anesthesia, yet have either incomplete or insufficient relief of symptoms by medical therapy or are unwilling to commit to lifelong medical therapy," said lead author, Claus Roehrborn, M.D., department of urology, The University of Texas-Southwestern Medical Center. The article in Urology also references an additional study of 150 TUNA patients with sustained relief of BPH symptoms at two years. The TUNA System is used to treat the symptoms associated with BPH which affects approximately 13 million men in the U.S., 23 million world-wide. In total, 10,000 TUNA procedures have been performed world-wide, 4,000 in the U.S. TUNA is a minimally-invasive procedure for treating BPH, requiring only a local anesthetic and, based upon currently available published clinical data, has the least post-procedural complications of any thermal or surgical procedure to treat this condition. More information on: Vidamed and Tuna.
|